Skip to main content

Thromboprophylaxis and Seizure Management in Intracerebral Hemorrhage

  • Chapter
  • First Online:
  • 544 Accesses

Abstract

Patients with intracranial hemorrhage (ICH) are at increased risk for venous thromboembolism (VTE) and epileptic seizures. After spontaneous ICH, lower limb deep vein thrombosis (DVT) and subsequent pulmonary embolism increase the morbidity and mortality, and their prevention is of paramount importance. The use of pneumatic intermittent lower limb compression devices and early introduction of unfractionated or low-molecular-weight heparin after cessation of bleeding are well studied and represent efficient preventive treatment options. Patients with ICH should have intermittent pneumatic compression devices placed from the first day of hospital admission to prevent VTE. Graduated compression stockings are not beneficial to reduce DVT or improve outcome. After documentation of cessation of bleeding, low-dose anticoagulation with subcutaneous low-molecular-weight heparin or unfractionated heparin may be considered for prevention of VTE in patients with lack of mobility after 1–4 days from onset. Systemic anticoagulation or inferior vena cava (IVC) filter placement is indicated for those ICH patients complicated with DVT or pulmonary embolism. IVC filter placement should be preferred in patients with unstable hematoma at high risk of expansion and in patients with anticoagulation-related ICH. Patients with clinical seizures should be treated with antiepileptic drugs (AEDs). The latter also should be administered to patients with a decline in mental status who are found to have electrographic seizures on electroencephalogram. However, there are inconsistent data regarding seizure prevention in ICH. Although administration of prophylactic AEDs is a common practice, there is a lack of high-quality data from randomized clinical trials supporting their routine use. Early occurrence of seizures appears not to increase the risk of epilepsy, and prophylactic AED therapy does not prevent late seizures and epilepsy. Moreover, early epileptic seizures in patients with ICH do not worsen outcome, whereas prophylactic use of some antiepileptic drugs (phenytoin in particular) may be associated with adverse functional outcomes. In this section, we review the currently available data regarding the management of thromboprophylaxis and epileptic seizures following spontaneous ICH.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Van Asch C, Luitse MA, Rinkel GE, van der Tweel I, Klijn CM. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.

    Article  PubMed  Google Scholar 

  2. Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dennis MS. Outcome after brain haemorrhage. Cerebrovasc Dis. 2003;16(Suppl 1):9–13.

    Article  PubMed  Google Scholar 

  4. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450–60.

    Article  PubMed  CAS  Google Scholar 

  5. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil. 2003;82:364–9.

    PubMed  Google Scholar 

  6. Amin AN, Lin J, Thompson S, Wiederkehr D. Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States. BMC Neurol. 2013;13:17.

    Article  PubMed  PubMed Central  Google Scholar 

  7. CLOTS Trials Collaboration, Dennis M, Sandercock PA, Reid J, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373:1958–65.

    Article  Google Scholar 

  8. Pongmoragot J, Rabinstein AA, Nilanont Y, Swartz RH, Zhou L, Saposnik G. Pulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcome. J Am Heart Assoc. 2013;2:e000372.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005;96:1731–3.

    Article  PubMed  Google Scholar 

  10. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of legs after strokes: part I – incidence and predisposing factors. Part II – natural history. Br Med J. 1976:1178–83.

    Google Scholar 

  11. Browd SR, Ragel BT, Davis GE, Scott AM, Skalabrin EJ, Couldwell WT. Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus. 2004;17:E1.

    Article  PubMed  Google Scholar 

  12. Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg. 2011;114:40–6.

    Article  PubMed  Google Scholar 

  13. Andre` C, De Freitas GR, Fukujima MM. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles. Eur J Neurol. 2007;14:21–32.

    Article  CAS  Google Scholar 

  14. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:630S–69S.

    Article  PubMed  CAS  Google Scholar 

  15. Kappelle LJ. Preventing deep vein thrombosis after stroke: strategies and recommendations. Curr Treat Options Neurol. 2011;13:629–35.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.

    Article  PubMed  CAS  Google Scholar 

  17. Kawase K, Okazaki S, Toyoda K, et al. Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage. Cerebrovasc Dis. 2009;27:313–9.

    Article  PubMed  Google Scholar 

  18. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci. 2008;272:83–8.

    Article  PubMed  Google Scholar 

  19. Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997;72:297–300.

    Article  PubMed  CAS  Google Scholar 

  20. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363:266–74.

    Article  PubMed  CAS  Google Scholar 

  21. Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following intracerebral hemorrhage. Neurocrit Care. 2009;10:28–34.

    Article  PubMed  CAS  Google Scholar 

  22. Kim KS, Brophy GM. Symptomatc venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care. 2009;11:28–33.

    Article  PubMed  Google Scholar 

  23. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score. J Thromb Haemost. 2010;8:2450–7.

    Article  PubMed  CAS  Google Scholar 

  24. Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204:1211–21.

    Article  PubMed  Google Scholar 

  25. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70–8.

    Article  PubMed  Google Scholar 

  26. Laryea J, Champagne B. Venous thromboembolism prophylaxis. Clin Colon Rectal Surg. 2013;26:153–9.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.

    Article  PubMed  Google Scholar 

  28. Dentali F, Marchesi C, Pierfranceschi MG, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011;106:429–38.

    Article  PubMed  CAS  Google Scholar 

  29. Robinson MT, Rabinstein AA, Meschia JF, Freeman WD. Safety of recombinant activated factor VII in patients with warfarin associated hemorrhages of the central nervous system. Stroke. 2010;41:1459–63.

    Article  PubMed  CAS  Google Scholar 

  30. Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.

    Article  PubMed  CAS  Google Scholar 

  31. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.

    Article  PubMed  CAS  Google Scholar 

  32. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001–23.

    Article  PubMed  Google Scholar 

  33. Prabhakaran S, Herbers P, Khoury J, et al. Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage? Stroke. 2015;46:369–75.

    Article  PubMed  CAS  Google Scholar 

  34. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9:840–55.

    Article  PubMed  Google Scholar 

  35. Shinohara Y, Yanagihara T, Abe K, et al. III. Intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2011;20:S74–99.

    Article  PubMed  Google Scholar 

  36. Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;155:625–32.

    Article  PubMed  Google Scholar 

  37. Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e601S–36S.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. National Stroke Foundation. Clinical guidelines for stroke management 2010. http://strokefoundation.com.au/health-professionals/tools-andresources/clinical-guidelines-for-stroke-prevention-and-management/

  39. National Institute for Health and Care Excellence (NICE). Reducing the risk of VTE (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. http://guidance.nice.org.uk/CG92

  40. Nyquist P, Bautista C, Jichici D, et al. Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24:47–60.

    Article  PubMed  CAS  Google Scholar 

  41. Sabri S, Roberts VC, Cotton LT. Prevention of early postoperative deep vein thrombosis by intermittent compression of the leg during surgery. Br Med J. 1971;4:394–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Hills NH, Pflug JJ, Jeyasingh K, Boardman L, Calnan JS. Prevention of deep vein thrombosis by intermittent pneumatic compression of calf. Br Med J. 1972;1:131–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Roberts VC, Cotton LT. Prevention of postoperative deep vein thrombosis in patients with malignant disease. Br Med J. 1974;1:358–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Turpie AG, Gallus A, Beattie WS, Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology. 1977;27:435–8.

    Article  PubMed  CAS  Google Scholar 

  45. Skillman JJ, Collins RE, Coe NP, et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery. 1978;83:354–8.

    PubMed  CAS  Google Scholar 

  46. Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology. 1998;50:1683–8.

    Article  PubMed  CAS  Google Scholar 

  47. Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology. 2005;65:865–9.

    Article  PubMed  CAS  Google Scholar 

  48. Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G, et al. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382:516–24.

    Article  PubMed  CAS  Google Scholar 

  49. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM. 2000;93:359–64.

    Article  PubMed  CAS  Google Scholar 

  50. CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med. 2010;153:553–62.

    Article  Google Scholar 

  51. Handley AJ, Emerson PA, Fleming PR. Heparin in the prevention of deep vein thrombosis after myocardial infarction. Br Med J. 1972;2:436–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Abraham-Inpijn L, Vreeken J. Effect of low-dose heparin on incidence of postoperative thrombosis in orthopaedic patients. Arch Chir Neerl. 1975;27:63–8.

    PubMed  CAS  Google Scholar 

  53. Sagar S, Nairn D, Stamatakis JD, et al. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet. 1976;1:1151–4.

    Article  PubMed  CAS  Google Scholar 

  54. Kutnowski M, Vandendris M, Steinberger R, Kraytman M. Prevention of postoperative deep-vein thrombosis by low-dose heparin in urological surgery. A double-blind, randomised study. Urol Res. 1977;5:123–5.

    Article  PubMed  CAS  Google Scholar 

  55. Dechavanne M, Ville D, Viala JJ, et al. Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis. 1975;4:94–100.

    PubMed  CAS  Google Scholar 

  56. Gallus AS, Hirsh J, O'Brien SE, McBride JA, Tuttle RJ, Gent M. Prevention of venous thrombosis with small, subcutaneous doses of heparin. JAMA. 1976;235:1980–2.

    Article  PubMed  CAS  Google Scholar 

  57. McCarthy ST, Turner JJ, Robertson D, Hawkey CJ, Macey DJ. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet. 1977;2:800–1.

    Article  PubMed  CAS  Google Scholar 

  58. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing. 1986;15:84–8.

    Article  PubMed  CAS  Google Scholar 

  59. Turpie AG, Levine MN, Hirsh J, et al. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet. 1987;1:523–6.

    Article  PubMed  CAS  Google Scholar 

  60. Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJ. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis. 1989;19:245–50.

    PubMed  CAS  Google Scholar 

  61. Turpie AG, Gent M, Côte R, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992;117:353–7.

    Article  PubMed  CAS  Google Scholar 

  62. Diener HC, Ringelstein EB, von Kummer R, et al. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT trial. Stroke. 2006;37:139–44.

    Article  PubMed  CAS  Google Scholar 

  63. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL study): an open-label randomised comparison. Lancet. 2007;369:1347–55.

    Article  PubMed  CAS  Google Scholar 

  64. Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study. Arch Phys Med Rehabil. 2004;85:1070–5.

    Article  PubMed  Google Scholar 

  65. Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr. 1988;66:1182–3.

    Article  PubMed  CAS  Google Scholar 

  66. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54:466–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care. 2009;10:28–34.

    Article  PubMed  CAS  Google Scholar 

  68. Kleindienst A, Harvey HB, Mater E, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir. 2003;145:1085–90.

    Article  PubMed  CAS  Google Scholar 

  69. Tetri S, Hakala J, Juvela S, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res. 2008;123:206–12.

    Article  PubMed  CAS  Google Scholar 

  70. Wasay M, Khan S, Zaki KS, Khealani BA, Kamal A, Azam I, et al. A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral haemorrhage. J Pak Med Assoc. 2008;58:362–4.

    PubMed  Google Scholar 

  71. Orken DN, Kenangil G, Ozkurt H, et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist. 2009;15:329–31.

    Article  PubMed  Google Scholar 

  72. Kiphuth IC, Staykov D, Köhrmann M, et al. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis. Cerebrovasc Dis. 2009;27:146–50.

    Article  PubMed  CAS  Google Scholar 

  73. Wu TC, Kasam M, Harun N, et al. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke. 2011;42:705–59.

    Article  PubMed  Google Scholar 

  74. Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acutecerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost. 2011;9:893–8.

    Article  PubMed  CAS  Google Scholar 

  75. Kelly J, Hunt BJ, Lewis RR, et al. Dehydration and venous thromboembolism after acute stroke. QJM. 2004;97:293–6.

    Article  PubMed  CAS  Google Scholar 

  76. Jauch EC, Saver JL, Adams HP Jr, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.

    Article  PubMed  Google Scholar 

  77. Govan L, Langhorne P, Weir CJ. Does the prevention of complications explain the survival benefi t of organized inpatient (stroke unit) care?: further analysis of a systematic review. Stroke. 2007;38:2536–40.

    Article  PubMed  Google Scholar 

  78. Allen C, Glasziou P, del Mar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet. 1999;354:1229–33.

    Article  PubMed  CAS  Google Scholar 

  79. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10:861–72.

    Article  PubMed  CAS  Google Scholar 

  80. Lynch E, Hillier S, Cadilhac D. When should physical rehabilitation commence after stroke: a systematic review. Int J Stroke. 2014;9:468–78.

    Article  PubMed  Google Scholar 

  81. Sundseth A, Thommessen B, Rønning OM. Early mobilization after acute stroke. J Stroke Cerebrovasc Dis. 2014;23:496–9.

    Article  PubMed  Google Scholar 

  82. Bernhardt J, Langhorne P, Lindley RI, et al. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015;386:46–55.

    Article  Google Scholar 

  83. Palareti G, Schellong S. Isolated distal deep vein thrombosis: what we know and what we are doing. J Thromb Haemost. 2012;10:11–9.

    Article  PubMed  CAS  Google Scholar 

  84. Johnson SA, Stevens SM, Woller SC, et al. Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis. JAMA. 2010;303:438–45.

    Article  PubMed  CAS  Google Scholar 

  85. Limbrey R, Howard L. Developments in the management and treatment of pulmonary embolism. Eur Respir Rev. 2015;24:484–97.

    Article  PubMed  Google Scholar 

  86. Hendriksen JM, Geersing GJ, Lucassen WA, et al. Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care. BMJ. 2015;351:h4438.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  87. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345:1326–30.

    Article  PubMed  CAS  Google Scholar 

  88. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001;135:98–107.

    Article  PubMed  CAS  Google Scholar 

  89. Kong XL, Zhang X, Zhang SJ, Zhang L. Plasma level of D-dimer is an independent diagnostic biomarker for deep venous thrombosis in patients with ischemic stroke. Curr Neurovasc Res. 2016;13:100–6.

    Article  PubMed  CAS  Google Scholar 

  90. Kelly J, Hunt BJ, Lewis RR, Rudd A. Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism? Stroke. 2003;34:2999–3005.

    Article  PubMed  CAS  Google Scholar 

  91. Nieto JA, Bruscas MJ, Ruiz-Ribo D, RIETE Investigators, et al. Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome. J Thromb Haemost. 2006;4:2367–72.

    Article  PubMed  CAS  Google Scholar 

  92. Hyers TM, Agnelli G, Hull RD. Antithrombotic therapy for venous thromboembolic disease. Chest. 1998;114(suppl):561S–78S.

    Article  PubMed  CAS  Google Scholar 

  93. Mismetti P, Laporte S, Pellerin O, PREPIC2 Study Group, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313:1627–35.

    Article  PubMed  Google Scholar 

  94. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–15.

    Article  PubMed  CAS  Google Scholar 

  95. Sung CY, Chu NS. Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1989;52:1273–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57:200–6.

    Article  PubMed  CAS  Google Scholar 

  97. Weisberg LA, Shamsnia M, Elliott D. Seizures caused by nontraumatic parenchymal brain hemorrhages. Neurology. 1991;41:1197–9.

    Article  PubMed  CAS  Google Scholar 

  98. Berger AR, Lipton RB, Lesser ML, Lantos G, Portenoy RK. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology. 1988;38:1363–5.

    Article  PubMed  CAS  Google Scholar 

  99. Neshige S, Kuriyama M, Yoshimoto T, et al. Seizures after intracerebral hemorrhage; risk factor, recurrence, efficacy of antiepileptic drug. J Neurol Sci. 2015;359:318–22.

    Article  PubMed  Google Scholar 

  100. Mullen MT, Kasner SE, Messé SR. Seizures do not increase in-hospital mortality after intracerebral hemorrhage in the nationwide inpatient sample. Neurocrit Care. 2013;19:19–24.

    Article  PubMed  Google Scholar 

  101. Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175–80.

    Article  PubMed  Google Scholar 

  102. De Herdt V, Dumont F, Hénon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77:1794–800.

    Article  PubMed  Google Scholar 

  103. Srinivasan S, Shin H, Chou SH, Pennell PB, Dworetzky BA, Lee JW. Seizures and antiepileptic drugs in patients with spontaneous intracerebral hemorrhages. Seizure. 2013;22:512–6.

    Article  PubMed  Google Scholar 

  104. Arntz R, Rutten-Jacobs L, Maaijwee N, et al. Post-stroke epilepsy in young adults: a long-term follow-up study. PLoS One. 2013;8:e55498.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  105. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire community stroke project. BMJ. 1997;315:1582–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  106. Faught E, Peters D, Bartolucci A, Moore L, Miller PC. Seizures after primary intracerebral hemorrhage. Neurology. 1989;39:1089–93.

    Article  PubMed  CAS  Google Scholar 

  107. Claassen J, Jetté N, Chum F, Green R, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.

    Article  PubMed  CAS  Google Scholar 

  108. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441–6.

    Article  PubMed  CAS  Google Scholar 

  109. De Reuck J, Hemelsoet D, Van Maele G. Seizures and epilepsy in patients with a spontaneous intracerebral haematoma. Clin Neurol Neurosurg. 2007;109:501–14.

    Article  PubMed  Google Scholar 

  110. Jensen MB, Sattar A, Al Sherbini K. Survey of prophylactic antiseizure drug use for non-traumatic intracerebral hemorrhage. Neurol Res. 2013;35:984–7.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Szaflarski JP, Rackley AY, Kleindorfer DO, et al. Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia. 2008;49:974–81.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Burneo JG, Fang J, Saposnik G, Investigators of the Registry of the Canadian Stroke Network. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol. 2010;17:52–8.

    Article  PubMed  CAS  Google Scholar 

  113. Sheth KN, Martini SR, Moomaw CJ, et al. Prophylactic antiepileptic drug use and outcome in the ethnic/racial variations of intracerebral hemorrhage study. Stroke. 2015;46:3532–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  114. Sykes L, Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev. 2014:CD005398.

    Google Scholar 

  115. Gilad R, Boaz M, Dabby R, Sadeh M, Lampl Y. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment? Epilepsy Res. 2011;95:227–31.

    Article  PubMed  Google Scholar 

  116. Reddig RT, Nixdorf KE, Jensen MB. The prophylactic use of an antiepileptic drug in intracerebral hemorrhage. Clin Neurol Neurosurg. 2011;113:895–7.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Woo KM, Yang SY, Cho KT. Seizures after spontaneous intracerebral hemorrhage. J Korean Neurosurg Soc. 2012;52:312–9.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Messé SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE, et al. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.

    Article  PubMed  CAS  Google Scholar 

  119. Naidech AM, Garg RK, Liebling S, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40:3810–5.

    Article  PubMed  CAS  Google Scholar 

  120. Lodder J, van Raak L, Hilton A, Hardy E, Kessels A, EGASIS Study Group. Diazepam to improve acute stroke outcome: results of the early GABA-Ergic activation study in stroke trial. A randomized double-blind placebo-controlled trial. Cerebrovasc Dis. 2006;21:120–7.

    Article  PubMed  CAS  Google Scholar 

  121. Hu X, Fang Y, Li H. Protocol for seizure prophylaxis following intracerebral hemorrhage study (SPICH): a randomized, double-blind, placebo-controlled trial of short-term sodium valproate prophylaxis in patients with acute spontaneous supratentorial intracerebral hemorrhage. Int J Stroke. 2014;9:814–7.

    Article  PubMed  CAS  Google Scholar 

  122. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.

    Article  PubMed  Google Scholar 

  123. Zandieh A, Messé SR, Cucchiara B, Mullen MT, Kasner SE, VISTA-ICH Collaborators. Prophylactic use of antiepileptic drugs in patients with spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2016. pii: S1052-3057(16)30099-4.

    Google Scholar 

  124. Battey TW, Falcone GJ, Ayres AM, et al. Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care. 2012;17:361–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  125. Gilmore E, Choi HA, Hirsch LJ, Claassen J. Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage. Neurologist. 2010;16:165–75.

    Article  PubMed  Google Scholar 

  126. Dewolfe JL, Szaflarski JP. Levetiracetam use in the critical care setting. Front Neurol. 2013;4:121.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Belcastro V, Costa C, Galletti F, et al. Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. Epilepsy Res. 2008;82:223–6.

    Article  PubMed  CAS  Google Scholar 

  128. Kutlu G, Gomceli YB, Unal Y, Inan LE. Levetiracetam monotherapy for late poststroke seizures in the elderly. Epilepsy Behav. 2008;13:542–4.

    Article  PubMed  Google Scholar 

  129. Taylor S, Heinrichs RJ, Janzen JM, Ehtisham A. Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage. Neurocrit Care. 2011;15:80–4.

    Article  PubMed  CAS  Google Scholar 

  130. Brophy GM, Bell R, Claassen J, et al. Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kargiotis, O., Tsivgoulis, G., Suarez, J.I. (2018). Thromboprophylaxis and Seizure Management in Intracerebral Hemorrhage. In: Ovbiagele, B., Qureshi, A. (eds) Intracerebral Hemorrhage Therapeutics. Springer, Cham. https://doi.org/10.1007/978-3-319-77063-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-77063-5_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-77062-8

  • Online ISBN: 978-3-319-77063-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics